Franklin Global Quality Dividend vs UBS Lux Equity Fund Biotech USD

Franklin Global Quality Dividend vs UBS Lux Equity Fund Biotech USD

1. Franklin Global Quality Dividend

  • Security

    Franklin Global Quality Dividend UCITS ETF

  • Fee

    0.45%

  • ISIN

    IE00BF2B0M76

  • Holdings

    20

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 27 holdings in Franklin Global Quality Dividend, where the largest holding is Broadcom (2.39), followed by AbbVie (2.37) and Qualcomm (2.2). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in Franklin Global Quality Dividend and UBS Lux Equity Fund Biotech USD.

Franklin Global Quality Dividend UBS Lux Equity Fund Biotech USD
1. Broadcom Inc
USA
2.39 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. AbbVie Inc
USA
2.37 %
2. Moderna Inc
9.21 %
3. Qualcomm Inc
USA
2.2 %
3. Vertex Pharmaceuticals Inc
8.44 %
4. Amgen Inc
USA
2.19 %
4. Alnylam Pharmaceuticals Inc
8.08 %
5. Merck & Co Inc
Germany
2.18 %
5. AbbVie Inc
USA
4.91 %
6. Novartis AG
Switzerland
2.13 %
6. Gilead Sciences Inc
USA
4.66 %
7. 3M Co
USA
2.12 %
7. Amgen Inc
USA
4.43 %
8. Royal Bank of Canada
Canada
2.11 %
8. BioNTech SE
4.13 %
9. Commonwealth Bank of Australia
Australia
2.1 %
9. Karuna Therapeutics Inc
3.75 %
10. Texas Instruments Inc
USA
2.09 %
-
11. Taiwan Semiconductor Manufacturing Company
Taiwan
2.04 %
-
12. Emerson Electric Co
USA
2.03 %
-
13. Johnson & Johnson Inc
USA
2.03 %
-
14. Allianz SE
Germany
2.03 %
-
15. Eaton Corporation Plc
Ireland USA
2 %
-
16. Cisco Systems Inc
USA
1.99 %
-
17. United Parcel Service Inc
USA
1.98 %
-
18. Coca-Cola Company
USA
1.94 %
-
19. Lockheed Martin Corp
USA
1.93 %
-
20. Paychex Inc
USA
1.93 %
-

The list of fund holdings was last updated on July 25, 2025.